DE50307184D1 - Kombination von loteprednoletabonat und dfho zur behandlung von atemwegserkrankungen, allergischen erkrankungen, asthma und copd - Google Patents

Kombination von loteprednoletabonat und dfho zur behandlung von atemwegserkrankungen, allergischen erkrankungen, asthma und copd

Info

Publication number
DE50307184D1
DE50307184D1 DE50307184T DE50307184T DE50307184D1 DE 50307184 D1 DE50307184 D1 DE 50307184D1 DE 50307184 T DE50307184 T DE 50307184T DE 50307184 T DE50307184 T DE 50307184T DE 50307184 D1 DE50307184 D1 DE 50307184D1
Authority
DE
Germany
Prior art keywords
diseases
copd
asthma
treatment
loteprednoletabonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50307184T
Other languages
German (de)
English (en)
Inventor
Mathias Locher
Robert Hermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharma GmbH and Co KG
Original Assignee
Meda Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meda Pharma GmbH and Co KG filed Critical Meda Pharma GmbH and Co KG
Application granted granted Critical
Publication of DE50307184D1 publication Critical patent/DE50307184D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DE50307184T 2002-08-09 2003-08-04 Kombination von loteprednoletabonat und dfho zur behandlung von atemwegserkrankungen, allergischen erkrankungen, asthma und copd Expired - Lifetime DE50307184D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10236688 2002-08-09
PCT/EP2003/008607 WO2004019984A1 (fr) 2002-08-09 2003-08-04 Nouvelle combinaison de glucocorticoides et d'inhibiteurs de pde-4 pour traiter des maladies des voies respiratoires, des maladies allergiques, de l'asthme et des maladies pulmonaires chroniques obstructives

Publications (1)

Publication Number Publication Date
DE50307184D1 true DE50307184D1 (de) 2007-06-14

Family

ID=31968961

Family Applications (1)

Application Number Title Priority Date Filing Date
DE50307184T Expired - Lifetime DE50307184D1 (de) 2002-08-09 2003-08-04 Kombination von loteprednoletabonat und dfho zur behandlung von atemwegserkrankungen, allergischen erkrankungen, asthma und copd

Country Status (19)

Country Link
US (1) US20050288265A1 (fr)
EP (1) EP1526870B1 (fr)
JP (1) JP2005539042A (fr)
CN (1) CN1308038C (fr)
AT (1) ATE361076T1 (fr)
AU (1) AU2003255365B2 (fr)
CA (1) CA2492645A1 (fr)
CY (1) CY1107696T1 (fr)
DE (1) DE50307184D1 (fr)
DK (1) DK1526870T3 (fr)
EA (1) EA008981B1 (fr)
ES (1) ES2285238T3 (fr)
HK (1) HK1078463A1 (fr)
HR (1) HRP20050224B1 (fr)
MX (1) MXPA05001573A (fr)
NO (1) NO20051212D0 (fr)
PT (1) PT1526870E (fr)
UA (1) UA82323C2 (fr)
WO (1) WO2004019984A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10241407A1 (de) * 2002-09-06 2004-03-18 Elbion Ag Behandlung nicht allergischer Rhinitis durch selektive Phosphodiesterase 4-Hemmstoffe
CA2550848C (fr) * 2004-02-06 2013-02-26 Meda Pharma Gmbh & Co. Kg Combinaison d'anticholinergiques et d'inhibiteurs de phosphodiesterase type 4 pour le traitement de maladies respiratoires
SI1713473T1 (sl) * 2004-02-06 2013-06-28 Meda Pharma Gmbh & Co. Kg Kombinacija antiholinergikov in glukokortikoidov za dolgotranjno zdravljenje astme in KOPB
SI1863476T1 (sl) * 2005-03-16 2016-05-31 Meda Pharma Gmbh & Co. Kg Kombinacija antiholinergikov in antagonistov receptorja levkotriena za zdravljenje respiratornih bolezni
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
SI1971369T1 (sl) 2005-12-21 2009-12-31 Meda Pharma Gmbh & Co Kg Kombinacija R,R-glikopirolata,roliprama in budezonida za zdravljenje vnetnih bolezni
JP2009529053A (ja) * 2006-03-07 2009-08-13 コンビナトアールエックス インコーポレーティッド 免疫炎症性障害の処置のための組成物および方法
WO2008095136A2 (fr) 2007-01-31 2008-08-07 Henkin Robert I Procédés de détection de substances biologiques
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
CN102309756A (zh) * 2010-07-02 2012-01-11 天津金耀集团有限公司 含有磷酸二酯酶4抑制剂和糖皮质激素的治疗皮肤病的复方药物
JP6360039B2 (ja) 2012-05-03 2018-07-18 カラ ファーマシューティカルズ インコーポレイテッド 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US10688041B2 (en) * 2012-05-03 2020-06-23 Kala Pharmaceuticals, Inc. Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus
US10864219B2 (en) 2012-05-03 2020-12-15 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
WO2014143453A1 (fr) * 2013-03-15 2014-09-18 Henkin Robert I Traitement faisaint intervenir un inhibiteur de la phosphodiestérase
WO2015126944A1 (fr) 2014-02-18 2015-08-27 Henkin Robert I Procédés et compositions permettant de diagnostiquer et de traiter une perte et/ou une distorsion du goût ou de l'odorat

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
CA2280099C (fr) * 1997-02-05 2005-12-27 Jago Pharma Ag Formulations medicales pour aerosols
IL138847A0 (en) * 1998-04-28 2001-10-31 Dresden Arzneimittel New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
DE19917504A1 (de) * 1999-04-17 2000-10-19 Dresden Arzneimittel Verwendung von Hydroxyindolen, die Inhibitoren der Phosphodiesterase 4 sind, zur Therapie chronisch obstruktiver Lungenerkrankungen
DE19947234A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
US20040214805A1 (en) * 1999-11-02 2004-10-28 Smithkline Beecham Corporation Method and compositions for treating pulmonary diseases
ECSP003747A (es) * 1999-11-02 2002-05-23 Smithkline Beecham Corp Metodo y composiciones para el tratamiento de las enfermedades pulmonares
CA2408145A1 (fr) * 2000-05-19 2001-11-29 Mark R. Hellberg Derives de disulfure d'aniline servant a traiter des maladies allergiques
GB0123951D0 (en) * 2001-10-05 2001-11-28 Glaxo Group Ltd Therapies for treating respiratory diseases
US7141572B2 (en) * 2001-11-05 2006-11-28 Merck Patent Gesellschaft Hydrazono-malonitriles
US20030092706A1 (en) * 2001-11-09 2003-05-15 Johannes Barsig Combination

Also Published As

Publication number Publication date
UA82323C2 (uk) 2008-04-10
HK1078463A1 (en) 2006-03-17
AU2003255365A1 (en) 2004-03-19
JP2005539042A (ja) 2005-12-22
HRP20050224A2 (en) 2005-04-30
DK1526870T3 (da) 2007-09-10
NO20051212L (no) 2005-03-08
CY1107696T1 (el) 2013-04-18
NO20051212D0 (no) 2005-03-08
CN1308038C (zh) 2007-04-04
ATE361076T1 (de) 2007-05-15
CA2492645A1 (fr) 2004-03-11
EP1526870A1 (fr) 2005-05-04
EP1526870B1 (fr) 2007-05-02
US20050288265A1 (en) 2005-12-29
ES2285238T3 (es) 2007-11-16
AU2003255365B2 (en) 2009-02-19
EA200500328A1 (ru) 2005-06-30
WO2004019984A1 (fr) 2004-03-11
PT1526870E (pt) 2007-07-09
HRP20050224B1 (en) 2007-12-31
EA008981B1 (ru) 2007-10-26
MXPA05001573A (es) 2005-04-25
CN1674939A (zh) 2005-09-28

Similar Documents

Publication Publication Date Title
CY1107696T1 (el) Συνδιασμος εταβονικης λοτεπρεδνολης και dfho για την αντιμετωπιση αναπνευστικων παθησεων, αλλεργικων παθησεων, ασθματος και copd
MXPA02011311A (es) Composicion novedosa.
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
CY1110081T1 (el) Νεα συνθεση
ATE519488T1 (de) Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten
DE50311502D1 (de) Neue arzneimittel zur behandlung von chronisch obstruktiver lungenerkrankung
DE602005019416D1 (de) Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
IS7898A (is) Ný samverkandi samsetning sem felur í sér róflúmílast og formóteról
WO2005041864A3 (fr) Technique de traitement de prevention d'inflammation respiratoire avec un inhibiteur de cyclooxygenase-2 combine a un inhibiteur de phosphodiesterase 4 et compositions a partir de ceux-ci
ATE457731T1 (de) Kombination von verbindungen, die bei der behandlung von atemwegserkrankungen verwendet werden können, insbesondere bei chronisch obstruktiver lungenerkrankung (copd) und asthma
SE9900834D0 (sv) Novel combination
IS2576B (is) Samverkandi samsetning sem felur í sér róflúmílast og (R.R)-formóteról
MXPA04007294A (es) Composicion para inhalacion.
ATE306271T1 (de) Kombination von loteprednol und beta2- adrenozeptor-agonisten und ihre verwendung durch inhalation zur behandlung von asthma bronchiale
ATE526954T1 (de) Atomoxetin zur behandlung von allergischer rhinitis und asthma

Legal Events

Date Code Title Description
8364 No opposition during term of opposition